Kyle Piskel has served as Adaptive Biotechnologies' Chief Financial Officer since April 2024. He joined the company in September 2015 and held roles of increasing responsibility, including Principal Accounting Officer since October 2021 and Interim Chief Financial Officer from February 2022 to June 2022. Before joining Adaptive, Mr. Piskel was an Accounting Manager at Expedia Group from October 2014 to August 2015 and worked in the Assurance services practice at Ernst & Young LLP from August 2007 to October 2014. A former certified public accountant, he holds a BA in Business Administration from Eastern Washington University and a Master of Accountancy from Gonzaga University.